Price Momentum and Recent Performance
Apollo Hospitals closed at ₹7,705.00 on 24 Feb 2026, up from the previous close of ₹7,611.10, marking a daily gain of 1.23%. The stock traded within a narrow range, hitting a high of ₹7,708.45 and a low of ₹7,611.55 during the session. While the current price remains below its 52-week high of ₹8,099.00, it is comfortably above the 52-week low of ₹6,002.15, reflecting resilience amid broader market fluctuations.
Comparatively, Apollo’s returns have outpaced the Sensex across multiple timeframes. Over the past week, the stock gained 1.23% versus the Sensex’s 0.02%. More impressively, Apollo has delivered a 13.29% return over the last month compared to Sensex’s 2.15%, and a year-to-date gain of 9.41% while the Sensex declined by 2.26%. The one-year return stands at 21.90%, nearly double the Sensex’s 10.60%, and the five-year return is a robust 157.06%, significantly outperforming the Sensex’s 67.42%. This strong relative performance underscores Apollo’s market leadership within the hospital sector.
Technical Indicators: A Mixed Bag
The technical trend for Apollo Hospitals has shifted from mildly bearish to sideways, signalling a potential consolidation phase. The weekly Moving Average Convergence Divergence (MACD) indicator is bullish, suggesting upward momentum in the near term. Conversely, the monthly MACD remains mildly bearish, indicating some caution for longer-term investors.
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no definitive signal, hovering in neutral territory. This lack of momentum extremes suggests the stock is neither overbought nor oversold, consistent with the sideways trend.
Bollinger Bands provide a more optimistic outlook, with both weekly and monthly indicators showing bullish signals. This implies that price volatility is expanding upwards, potentially paving the way for a breakout if supported by volume.
Daily moving averages, however, remain mildly bearish, reflecting short-term selling pressure or profit-taking. The KST (Know Sure Thing) indicator is mildly bullish on the weekly chart but mildly bearish on the monthly, reinforcing the mixed momentum signals.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
Volume and Trend Confirmation
On-Balance Volume (OBV) analysis shows no clear trend on the weekly chart but indicates mild bearishness on the monthly scale. This divergence between price momentum and volume suggests that while prices have been rising recently, the underlying volume support is not yet robust enough to confirm a sustained uptrend.
Dow Theory assessments are mildly bullish on both weekly and monthly charts, signalling that the broader market sentiment for Apollo Hospitals remains cautiously optimistic. This aligns with the sideways technical trend, where investors may be awaiting clearer directional cues before committing further capital.
Mojo Score and Market Capitalisation Insights
Apollo Hospitals currently holds a Mojo Score of 61.0, categorised as a Hold, reflecting a downgrade from a previous Buy rating on 9 Jan 2026. This adjustment reflects the mixed technical signals and the cautious stance adopted by analysts. The company’s market capitalisation grade is 1, indicating a large-cap status with significant market presence and liquidity.
Given the hospital sector’s defensive qualities and Apollo’s leadership position, the Hold rating suggests investors should monitor technical developments closely before making fresh commitments. The sideways trend and mixed indicator signals imply that the stock may consolidate in the near term before resuming a clearer directional move.
Long-Term Performance and Sector Context
Over the longer term, Apollo Hospitals has demonstrated exceptional growth, with a 10-year return of 436.24%, far exceeding the Sensex’s 255.80%. This outperformance highlights the company’s ability to capitalise on India’s expanding healthcare demand and its strong operational execution.
Within the hospital sector, Apollo remains a bellwether stock, often setting the tone for peers. The current technical consolidation phase may represent a healthy pause following a strong rally, allowing the stock to build a base for future gains.
Apollo Hospitals Enterprise Ltd. or something better? Our SwitchER feature analyzes this large-cap Hospital stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaway
For investors, the current technical landscape of Apollo Hospitals suggests a period of consolidation with mixed signals from key indicators. The bullish weekly MACD and Bollinger Bands hint at potential upward momentum, but the mildly bearish monthly MACD and daily moving averages counsel caution. The neutral RSI readings further reinforce the sideways trend, indicating no immediate overbought or oversold conditions.
Given the stock’s strong relative performance against the Sensex and its leadership in the hospital sector, investors may consider maintaining existing positions while awaiting confirmation of a breakout or breakdown. Monitoring volume trends and the evolution of moving averages will be critical in assessing the next directional move.
In summary, Apollo Hospitals Enterprise Ltd. remains a fundamentally strong large-cap stock with a Hold rating reflecting the current technical uncertainty. The stock’s ability to sustain gains above ₹7,700 and break above the recent highs near ₹7,708 could signal renewed bullish momentum. Conversely, a failure to hold these levels may lead to further consolidation or mild correction.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
